(Q46948248)

English

The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome

scientific article published in December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

M Yilmaz

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

A Biri

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

A Karakoç

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

F Törüner

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

B Bingöl

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

N Cakir

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

B Tiras

7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

G Ayvaz

8

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

M Arslan

9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

publication date

1 December 2005

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

28

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

11

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

1003-1008

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

https://scigraph.springernature.com/pub.10.1007/bf03345339

0 references

What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Polycystic ovary syndrome and cardiovascular disease: a premature association?

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Current views on the mechanism of action of thiazolidinedione insulin sensitizers

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Clinical assessment of body hair growth in women

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Follow-up report on the diagnosis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Alternate pathway 17,20-lyase enzyme activity in the adrenals is enhanced in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Insulin action in the normal and polycystic ovary

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345339

21 January 2018

Polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16483179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16483179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16483179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can metformin reduce insulin resistance in polycystic ovary syndrome?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16483179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of metformin on early pregnancy loss in the polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16483179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16483179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16483179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03345339

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16483179

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46948248&oldid=2139418495"